Abstract
With the advent of potent immunosuppressive therapies in solid organ trans-plantation, patients are more susceptible to a variety of infections with atypical pathogens and presentations. We report a renal transplant recipient with atypical presentation of histoplasmosis.
MeSH terms
-
Antifungal Agents / therapeutic use
-
Drug Therapy, Combination
-
Histoplasma / pathogenicity*
-
Histoplasmosis / diagnosis
-
Histoplasmosis / drug therapy
-
Histoplasmosis / microbiology*
-
Humans
-
Immunosuppressive Agents / adverse effects*
-
Kidney Transplantation / adverse effects*
-
Male
-
Middle Aged
-
Treatment Outcome
Substances
-
Antifungal Agents
-
Immunosuppressive Agents